Proceedings of the National Academy of Sciences · 1995 · 447 citations · 16 references
Life SciencesInfectious DiseasesMolecular BiologyGene ExpressionMolecular VirologyVirologyRespiratory Infectious DiseasesViral Gene ExpressionViral InfectionsViral ReplicationViral TranscriptionViral VaccinesRespiratory Syncytial Virus VaccinesRespiratory Viral InfectionsRespiratory Viral PathogenesisVaccine Strain DevelopmentViral Polymerase GenesViral Respiratory InfectionsViral Transcription ElongationViral Transcription Factors
Infectious human respiratory syncytial virus (RSV) was produced by the intracellular coexpression of five plasmid-borne cDNAs. One cDNA encoded a complete positive-sense version of the RSV genome (corresponding to the replicative intermediate RNA or antigenome), and each of the other four encoded a separate RSV protein, namely, the major nucleocapsid N protein, the nucleocapsid P phosphoprotein, the major polymerase L protein, or the protein from the 5' proximal open reading frame of the M2 mRNA [M2(ORF1)]. RSV was not produced if any of the five plasmids was omitted. The requirement for the M2(ORF1) protein is consistent with its recent identification as a transcription elongation factor and confirms its importance for RSV gene expression. It should thus be possible to introduce defined changes into infectious RSV. This should be useful for basic studies of RSV molecular biology and pathogenesis; in addition, there are immediate applications to the development of live attenuated vaccine strains bearing predetermined defined attenuating mutations.
16